JULIE TOWNSEND: Open Payments
NPI 1962456673 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 19 payments from 12 companies in 2025. Trend: 2023 $725 · 2024 $701 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $52 |
| Amgen Inc. | 3 | $49 |
| ABBVIE INC. | 3 | $48 |
| PFIZER INC. | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: TRELEGY ELLIPTA, PREVNAR 20, VRAYLAR, OTEZLA, CAPVAXIVE, IBSRELA, EVENITY, GVOKE HYPOPEN.
Industry payments across AZ — which companies pay providers there.
